Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Research may hold key to maintaining embryonic stem cells in lab

Research may hold key to maintaining embryonic stem cells in lab

July 10, 2009

In a new study that could transform embryonic stem cell (ES cell) research, scientists at UT Southwestern Medical Center have discovered why mouse ES cells can be easily grown in a laboratory while other mammalian ES cells are difficult, if not impossible, to maintain.

If the findings in mice can be applied to other animals, scientists could have an entirely new palette of research tools to work with, said Dr. Steven McKnight, chairman of biochemistry at UT Southwestern and senior author of the study appearing in the July 9 issue of Science Express.




"This might change the way medical research is done. But it's still a big 'if,'" he said.

According to the research, the activation of a gene called TDH in mouse ES cells results in the cells entering a unique metabolic state that is similar to that of rapidly growing bacterial cells. The gene controls the production of the threonine dehydrogenase (TDH) enzyme in mouse ES cells. This enzyme breaks down an amino acid called threonine into two products. One of the two products goes on to control a cellular process called one carbon metabolism; the other provides ES cells with an essential metabolic fuel.

Both of the threonine breakdown products are necessary to keep the ES cells growing and dividing rapidly in a petri dish without differentiating into specific tissues.

The various substances currently used by scientists to keep mouse ES cells alive in the laboratory were found by trying many different combinations until something worked, Dr. McKnight said. But until now, it wasn't known that these culture conditions keyed into keeping the TDH gene actively expressed.

"Scientists added this and that until they got the right 'soup,' one that works in the mouse ES cells to somehow activate the TDH gene," he said, adding that exactly how that gene is regulated is still unknown.

Other mammalian species have a functional version of the TDH gene, suggesting the possibility that the process could also be activated in them.

"You would think that the 'mouse soup' would then work for all species, but it doesn't. Researchers have been trying for 20 years to get the right formula for maintaining ES cells from other species. With few exceptions, however, they still haven't gotten it right," Dr. McKnight said.

The research was funded by a National Institutes of Health Director's Pioneer Award, which Dr. McKnight received in 2004. The program encourages investigators to take on creative, unexplored avenues of research that carry a relatively high potential for failure but that also possess a greater chance for truly groundbreaking discoveries.

"By applying a highly innovative technique to manipulate the TDH gene, McKnight's work could be an important breakthrough with a profound impact on future research," said Dr. Raynard S. Kington, acting director of the NIH. "This research, which was partially funded by our Pioneer Award program, shows the value of supporting exceptionally creative approaches to major challenges in biomedical and behavioral research."

Embryonic stem cells are "blank slate" cells - derived from embryos - that go on to develop into any of the more than 200 types of cells in the adult body.

Because mouse ES cells are easily maintained in the lab, they can be manipulated genetically to produce adult mice in which various genes are either modified or eliminated. So-called "knockout mice" allow scientists to study the genetic aspects of many diseases and conditions, including cancer, Alzheimer's, Parkinson's and paralysis.

In the living mouse, and in other species, ES cells exist for only a short time. In that time, they need to grow rapidly in order to accumulate enough cells to begin the process of differentiating into all the body's cell types. Dr. McKnight hypothesizes that the TDH gene tightly controls this process in the animal, allowing the ES cells to grow, but then it shuts off when it's time to differentiate.

"If we can tweak conditions and determine how to keep the gene turned on in other animals, we might be able to grow and maintain ES cells for study in many species. It's still speculative at this point whether it will work, but if it does, then this may prove to represent a transformational discovery," Dr. McKnight said.

Interestingly, although humans carry a form of the TDH gene, it contains three inactivating mutations. As such, human ES cells do not produce the TDH enzyme.

"In the human embryo, something else is taking the place of this TDH-mediated form of rapid cell growth," Dr. McKnight said. "Human ES cells may exist in a unique metabolic state, but it would not appear to involve threonine breakdown."

Human ES cells grow slowly and are difficult to maintain in the laboratory, which is a huge impediment to this field of study, Dr. McKnight said.

"If scientists could repair the mutated human TDH gene and replace it into human ES cells, could they make those cells grow faster in culture? I don't know whether this will work or not - it's highly speculative. But if so, it would be profound," he said.

UT Southwestern Medical Center



Related Embryonic Stem Cells Current Events and Embryonic Stem Cells News Articles Embryonic Stem Cells Current Events and Embryonic Stem Cells News RSS Embryonic Stem Cells Current Events and Embryonic Stem Cells News RSS
New research shows versatility of amniotic fluid stem cells
For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought.

First reconstitution of an epidermis from human embryonic stem cells
Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM* Institute (I-STEM/ Inserm UEVE U861/AFM), published in the Lancet on 21 November 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells.

UCI embryonic stem cell therapy restores walking ability in rats with neck injuries
The first human embryonic stem cell treatment approved by the FDA for human testing has been shown to restore limb function in rats with neck spinal cord injuries - a finding that could expand the clinical trial to include people with cervical damage.

Of mice and men: Stem cells and ethical uncertainties
The recent creation of live mice from induced pluripotent stem cells (iPSCs) not only represents a remarkable scientific achievement, but also raises important issues, according to bioethicists at The Johns Hopkins University's Berman Institute of Bioethics.

NIH-funded researchers transform embryonic stem cells into human germ cells
Researchers funded in part by the National Institutes of Health have discovered how to transform human embryonic stem cells into germ cells, the embryonic cells that ultimately give rise to sperm and eggs.

Placental precursor stem cells require testosterone-free environment to survive
Trophoblast stem cells (TSCs), cells found in the layer of peripheral embryonic stem cells from which the placenta is formed, are thought to exhibit "immune privilege" that aids cell survivability and is potentially beneficial for cell and gene therapies.

Endocrine Society calls for expanded scope and funding for stem cell research
Stem cell research holds great promise for the treatment of millions of Americans with debilitating and possibly fatal diseases.

Small mechanical forces have big impact on embryonic stem cells
Applying a small mechanical force to embryonic stem cells could be a new way of coaxing them into a specific direction of differentiation, researchers at the University of Illinois report. Applications for force-directed cell differentiation include therapeutic cloning and regenerative medicine.

Fate Therapeutics announces creation of small molecule platform for commercial-scale reprogramming
Fate Therapeutics, Inc. announced today the generation of human induced-pluripotent stem cells (iPSCs) using a combination of small molecules that significantly improves the speed and efficiency of reprogramming.

A major step in making better stem cells from adult tissue
October 15, 2009 A team led by scientists from The Scripps Research Institute has developed a method that dramatically improves the efficiency of creating stem cells from human adult tissue, without the use of embryonic cells.
More Embryonic Stem Cells Current Events and Embryonic Stem Cells News Articles
Embryonic Stem Cells: A Practical Approach (The Practical Approach Series)

Embryonic Stem Cells: A Practical Approach (The Practical Approach Series)
by Elena Notarianni (Editor), Martin J. Evans (Editor)

The groundbreaking isolation of embryonic stem cells (or 'ES cells') of the mouse in the early 1980s triggered a sustained expansion of global research into their exploitation. This led to the routine genetic engineering of the mouse and revolutionised our understanding of biological processes in the context of the whole animal. ES cell biology remains a crucial and growing area of research with far-reaching implications for developmental and comparative biology as well as for human health.
This book serves as a primer to ES cells, their derivation and experimental manipulation. It contains a broad compendium of methods of direct relevance to both graduate students and specialist researchers. An introductory chapter by the principle originator of ES cell research outlines the...

Lines That Divide: The Great Stem Cell Debate

Lines That Divide: The Great Stem Cell Debate
Directed By: Brian Godawa
Also With: Jack Hafer (Producer), Jennifer Lahl (Producer)

With the Obama administration recently announcing its policy change on the issue of stem cell research and regenerative medicine, the questions surrounding this issue are increasingly more complex. This is why Lines That Divide: The Great Stem Cell Debate, a feature length documentary on stem cell research was made. Is stem cell research a potential miracle cure for diseases or a form of biological colonialism? The debate still rages over this controversial science. Supporters argue that it is our moral duty to pursue scientific progress that provides healing hope for humanity. Detractors argue that the ends don't justify the means in harvesting some human life to save others places our nations heart and soul on the same path as Germany in the late 1930's. This documentary seeks to...

The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy (Basic Bioethics)

The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy (Basic Bioethics)
by Suzanne Holland (Editor), Karen Lebacqz (Editor), Laurie Zoloth (Editor)

Human embryonic stem cells can divide indefinitely and have the potential to develop into many types of tissue. Research on these cells is essential to one of the most intriguing medical frontiers, regenerative medicine. It also raises a host of difficult ethical issues and has sparked great public interest and controversy. This book offers a foundation for thinking about the many issues involved in human embryonic stem cell research. It considers questions about the nature of human life, the limits of intervention into human cells and tissues, and the meaning of our corporeal existence. The fact that stem cells may be derived from living embryos that are destroyed in the process or from aborted fetuses ties the discussion of stem cell research to the ongoing debates on abortion. In...

ABC News Nightline Henry's Story

ABC News Nightline Henry's Story

For every medical breakthrough, there are many more patients who undergo experimental treatment only to see it fail. But even though the treatment fails, the patient still plays an important role, and offers a generous gift to our overall understanding of science. Laurie Strongin and Allen Goldberg did not seek the role they played in medical research. They found themselves there unexpectedly in 1995 when their first born, Henry, was diagnosed with a rare and deadly disease called Fanconi Anemia. Immediately, they were thrust onto the frontlines of medical research. Before Henry was a toddler they found themselves in the middle of a debate that would soon grip the nation over embryonic tissue research. But for Laurie and Allen there was never a debate. Doctors told them that the best...

Human Embryonic Stem Cells: An Introduction to the Science and Therapeutic Potential

Human Embryonic Stem Cells: An Introduction to the Science and Therapeutic Potential
by Ann A. Kiessling (Author), Scott. C. Anderson (Author)

The social debate and resulting moratorium by the Bush Administration against federal funding for research involving the creation of human embryos for stem cell therapy prompted the writing of this text. The emerging field of human embryonic stem cell biomedicine crosses many disciplinary boundaries - cell biology, reproductive biology, embryology, molecular biology, endocrinology, immunology, fetal medicine, transplantation medicine and surgery. This single reference provides basic information from these multiple disciplines as it pertains to the science of stem cells.

Human Embryonic Stem Cell Protocols (Methods in Molecular Biology)

Human Embryonic Stem Cell Protocols (Methods in Molecular Biology)
by Kursad Turksen (Editor)

Despite political and ethical controversies surrounding the study of human embryonic stem (hES) cells, new freedoms in regard to using them for research has allowed interest to remain high in understanding the regulatory mechanisms of stem cell self-renewal, their differentiation along various lineages, and their potential use in regenerative medicine. In Human Embryonic Stem Cell Protocols, Second Edition, internationally respected researchers expand upon the popular first edition and describe in detail their most useful techniques for the molecular and cellular manipulation of these intriguing cells. This diverse collection of readily reproducible methods has been optimized for the derivation, characterization, and differentiation of hES cells, with special attention given to...

Charlie Rose with Gerald Fischbach, Silviu Itescu, Bill Futrell, Arlen Specter & Sam Brownback; Christopher Reeve (May 4, 2001)

Charlie Rose with Gerald Fischbach, Silviu Itescu, Bill Futrell, Arlen Specter & Sam Brownback; Christopher Reeve (May 4, 2001)

A panel on stem cell research featuring Dr. Gerald Fischbach, Dean of the Columbia Medical School, Dr. Silviu Itescu, Director of Transplantation Immunology at Columbia, Dr. Bill Futrell, President-Elect of the American Association of Plastic Surgeons, Pennsylvania Senator Arlen Specter and Kansas Senator Sam Brownback. They share their thoughts on the medical benefits that the use of stem cells will lead to and the ethical questions that are implicit in this medical procedure. Then, Christopher Reeve is on to give his opinion on the topic and encourages pushing ahead with research.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

Human Embryonic Stem Cells: The Practical Handbook

Human Embryonic Stem Cells: The Practical Handbook
by Stephen Sullivan (Editor), Chad A Cowan (Editor), Kevin Eggan (Editor)

With this valuable practical guide, three members of the Harvard Stem Cell Institute have compiled and edited the definite handbook for the exciting new field of human embryonic stem cell research. The editors have gathered protocols from scientists with extensive reputation and expertise, describing and comparing currently used techniques for the culture of human stem cells and discussing the strengths and weaknesses of the different approaches.

Human Embryonic Stem Cells: The Practical Handbook contains the first centralised collection of methods used in human embryonic stem cell biology. The book covers the derivation of human stem cell lines, the obtaining of cells from human stem cell banks, the culturing and characterisation of the cells, and the differentiation of the...

The The Global Politics of Human Embryonic Stem Cell Science (Health Technology and Society Series)

The The Global Politics of Human Embryonic Stem Cell Science (Health Technology and Society Series)
by Herbert Gottweis (Author), Brian Salter (Author), Catherine Waldby (Author)

Features students and researchers in medical sociology, medicine and genetics, general politics of health, and comparative medical sociology.

Charlie Rose (August 9, 2001)

Charlie Rose (August 9, 2001)

In this rebroadcast of an hour that originally aired on May 4, 2001, a panel discusses their reactions to President Bush's announcement to allow limited federal funding for embryonic stem cell research. They are: Bill Kristol, Editor of The Weekly Standard Magazine, Senator Sam Brownback, Dr. Gerald Fischbach, Dean of the School of Medicine at Columbia University, Sharon Begley, senior editor at Newsweek Magazine, and Eric Pooley, an editor at Time Magazine.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

© 2009 BrightSurf.com